Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas

被引：10
|
作者：
Kim, S. H.
Kim, J. W. [2 ]
Kim, Y. T.
Kim, J. H.
Yoon, B. S.
Ryu, H. S.
机构：
[1] Ajou Univ, Coll Med, Dept Obstet & Gynecol, Suwon 441749, South Korea
[2] Yonsei Univ, Coll Med, Inst Womens Life Sci, Dept Obstet & Gynecol,Womens Canc Clin, Seoul 120749, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2006年 / 95卷 / 03期
关键词：
uterine sarcoma; clinicopathologic prognostic factors; p53; protein; mdm-2;
D O I：
10.1016/j.ijgo.2006.03.031
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Objectives: To evaluate the clinicopathologic prognostic factors of uterine sarcoma, and determine whether overexpression of p53 and mdm-2 proteins correlate with overall survival and prognostic factors. Methods: Thirty specimens from 43 patients with uterine sarcoma were available for slide review and evaluated by immunohistochemistry at Yonsei and Ajou University Medical Centers for the expression of p53 and mdm-2. Results: Overall survival was found to correlate to histologic type of uterine sarcoma, surgical stage, tumor grade, and mitotic index. Whereas 63% of the sarcomas expressed p53, with a significant correlation to overall survival, 60% expressed mdm-2, with a significant correlation to the mitotic index but not to overall survival. Conclusion: Histologic type, surgical stage, tumor grade, mitotic index, and p53 expression were prognostic factors of the overall survival of patients with uterine sarcoma. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd.
引用
收藏
页码：272 / 277
页数：6
相关论文
共 50 条
  • [1] Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas
    Seki, A
    Kodama, J
    Miyagi, Y
    Kamimura, S
    Yoshinouchi, M
    Kudo, T
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (01) : 33 - 37
  • [2] p53 and MDM-2 gene expression in human skin
    Dazard, JE
    Augias, D
    Neel, H
    Piette, J
    Guilhou, JJ
    BassetSeguin, N
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (05) : C41 - C41
  • [3] Mdm-2: ''Big brother'' of p53
    Momand, J
    Zambetti, GP
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1997, 64 (03) : 343 - 352
  • [4] MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS
    CHEN, JD
    MARECHAL, V
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) : 4107 - 4114
  • [5] P53 AND MDM-2 EXPRESSION IN MALIGNANT-MELANOMA - AN IMMUNOCYTOCHEMICAL STUDY OF EXPRESSION OF P53, MDM-2, AND MARKERS OF CELL-PROLIFERATION IN PRIMARY VERSUS METASTATIC TUMORS
    GELSLEICHTER, L
    GOWN, AM
    ZARBO, RJ
    WANG, E
    COLTRERA, MD
    [J]. MODERN PATHOLOGY, 1995, 8 (05) : 530 - 535
  • [6] THE P53 MDM-2 AUTOREGULATORY FEEDBACK LOOP
    WU, XW
    BAYLE, JH
    OLSON, D
    LEVINE, AJ
    [J]. GENES & DEVELOPMENT, 1993, 7 (7A) : 1126 - 1132
  • [7] Role of p53 and mdm-2 in osteoblast differentiation
    Chandar, N
    Bovenkerk, S
    Nerney, M
    [J]. BONE, 2001, 28 (05) : S153 - S153
  • [8] EXPRESSION OF MDM-2 AND P53 PROTEIN IN TRANSITIONAL-CELL CARCINOMA
    BARBARESCHI, M
    GIRLANDO, S
    FELLIN, G
    GRAFFER, U
    LUCIANI, L
    DALLAPALMA, P
    [J]. UROLOGICAL RESEARCH, 1995, 22 (06): : 349 - 352
  • [9] P53 MUTATION, MDM-2 EXPRESSION, AND SUBTYPE SPECIFICITY IN CHILDHOOD RHABDOMYOSARCOMA
    LOPEZTERRADA, D
    ZOVICH, D
    BIGGS, C
    TRICHE, TJ
    [J]. LABORATORY INVESTIGATION, 1993, 68 (01) : A127 - A127
  • [10] Expression and significance of P53 protein and MDM-2 protein in human gliomas
    Wang An-liu
    Liu Zhao-xia
    Li Guang
    Zhang Li-Wei
    [J]. CHINESE MEDICAL JOURNAL, 2011, 124 (16) : 2530 - 2533
12345